Kiniksa Pharmaceuticals Ownership | Who Owns Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals Ownership Summary
Kiniksa Pharmaceuticals is owned by 0.18% institutional investors, 4.15% insiders, and 95.67% retail investors. Birchview capital, lp is the largest institutional shareholder, holding 0.04% of KNSA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.60% of its assets in Kiniksa Pharmaceuticals shares.
KNSA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Kiniksa Pharmaceuticals | 0.18% | 4.15% | 95.67% |
Sector | Healthcare Stocks | 46.80% | 8.14% | 45.06% |
Industry | Biotech Stocks | 44.70% | 7.99% | 47.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Birchview capital, lp | 30.00K | 0.04% | $560.10K |
Geode capital management | - | - | - |
Prudential financial | - | - | - |
Arrowmark colorado | - | - | - |
National bank of canada /fi/ | - | - | - |
Cerity partners | - | - | - |
Voya investment management | - | - | - |
Parallel advisors | - | - | - |
Essex investment management | - | - | - |
Capula management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Birchview capital, lp | 30.00K | 0.52% | $560.10K |
Geode capital management | - | - | - |
Prudential financial | - | - | - |
Arrowmark colorado | - | - | - |
National bank of canada /fi/ | - | - | - |
Cerity partners | - | - | - |
Voya investment management | - | - | - |
Parallel advisors | - | - | - |
Essex investment management | - | - | - |
Capula management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Birchview capital, lp | 30.00K | 0.52% | - |
Pnc financial services group | - | - | -8.00 |
Riggs asset managment | - | - | -30.00 |
Nelson, van denburg & campbell wealth management group | - | - | -34.00 |
Nisa investment advisors | - | - | -58.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | - | - | -4.19M |
Fairmount funds management | - | - | -3.20M |
Hhlr advisors | - | - | -3.14M |
Vanguard group | - | - | -2.98M |
Baker bros. advisors lp | - | - | -2.81M |
Sold Out
Holder | Change |
---|---|
Pnc financial services group | -8.00 |
Riggs asset managment | -30.00 |
Nelson, van denburg & campbell wealth management group | -34.00 |
Nisa investment advisors | -58.00 |
Us bancorp \de\ | -116.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 2 | -60.00% | 127,543 | 90.97% | - | 1987.95% | 1 | -66.67% | - | - |
Jun 30, 2024 | 5 | -96.88% | 66,788 | -99.83% | - | 0.00% | 3 | -96.47% | - | -100.00% |
Mar 31, 2024 | 160 | 6.67% | 38,944,112 | 13.77% | 55 | 2.33% | 85 | 23.19% | 48 | -14.29% |
Dec 31, 2023 | 150 | 3.45% | 34,231,785 | -1.90% | 48 | 1.96% | 69 | - | 56 | 24.44% |
Sep 30, 2023 | 145 | 6.62% | 34,893,836 | 9.74% | 49 | 2.40% | 69 | 1.47% | 45 | 4.65% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.16M | 1.60% | -92.28K |
Pictet Biotech | 965.39K | 1.36% | 965.39K |
iShares Russell 2000 ETF | 968.27K | 1.34% | -2.17K |
Pictet-Biotech P USD | 956.36K | 1.32% | -5.26K |
Vanguard Small Cap Index | 918.92K | 1.27% | 1.80K |
Pictet-Global Megatrend Sel I USD | 595.91K | 0.83% | 264.50K |
Vanguard Institutional Extnd Mkt Idx Tr | 567.21K | 0.80% | 795.00 |
Fidelity Small Cap Growth | 491.51K | 0.68% | 137.52K |
Fidelity Small Cap Index | 383.10K | 0.53% | -10.28K |
Nuveen Quant Small Cap Equity R6 | 336.74K | 0.47% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 18, 2024 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | $357.68K |
Nov 06, 2024 | Patel Sanj K | CHAIRMAN & CEO | Sell | $2.06M |
Oct 15, 2024 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | $456.79K |
Sep 23, 2024 | Tessari Eben | CHIEF OPERATING OFFICER | Sell | $437.32K |
Sep 03, 2024 | Paolini John F. | CHIEF MEDICAL OFFICER | Sell | $40.10K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 3 |
2024 Q3 | - | 14 |
2024 Q2 | - | - |
2024 Q1 | - | 11 |
2023 Q4 | - | 5 |
KNSA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools